Hyderabad Telangana, India

Bharath Kumar Gajjela

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bharath Kumar Gajjela. Retrieved from https://idiyas.com/inventor/bharath-kumar-gajjela

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Anticancer Agents by Bharath Kumar Gajjela

Introduction

Bharath Kumar Gajjela is an innovative inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of potential anticancer agents. His work focuses on synthesizing compounds that can combat human cancer cell lines effectively.

Latest Patents

Bharath Kumar Gajjela holds a patent for "3,4,5-trimethoxystyrylarylaminopropenones as potential anticancer agents." This invention relates to compounds of general formula A. The patent outlines the synthesis of 3,4,5-trimethoxystyrylarylaminopropenones, which are useful as potential antitumor agents against human cancer cell lines. The process for the preparation of these compounds is also detailed in the patent.

Career Highlights

Bharath Kumar Gajjela is associated with the Council of Scientific and Industrial Research, where he conducts research aimed at developing new therapeutic agents. His dedication to scientific research has led to advancements in the fight against cancer.

Collaborations

Bharath has collaborated with notable colleagues, including Santhosh Reddy Vangala and Rasala Mahesh. These collaborations have enhanced the research efforts in the field of anticancer drug development.

Conclusion

Bharath Kumar Gajjela's work in synthesizing potential anticancer agents showcases his commitment to advancing medical science. His contributions are vital in the ongoing battle against cancer, and his innovative spirit continues to inspire future research in this critical area.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…